The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Ligand-targeted therapeutics in anticancer therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer
Behr, T. M., Liersch, T., Greiner‐Bechert, L., Griesinger, F., Béhé, M. P., Markus, P. M., Gratz, S., Angerstein, C., Brittinger, G., Heinz Becker, A., et al. (2002) · Cancer · doi:10.1002/cncr.10308 · Cited by 110
RetractedContinuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size.
Yuan, F., Dellian, M., Fukumura, D., Leunig, M., Berk, D. A., Torchilin, V. P., & Jain, R. K. (1995) · PubMed · Cited by 1,711
Openings Between Defective Endothelial Cells Explain Tumor Vessel Leakiness
Hashizume, H., Baluk, P., Morikawa, S., McLean, J. W., Thurston, G., Roberge, S., Jain, R. K., & McDonald, D. M. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65006-7 · Cited by 1,689
Optimizing Liposomes for Delivery of Chemotherapeutic Agents to Solid Tumors
Drummond, D. C., Meyer, O., Hong, K., Kirpotin, D. B., & Papahadjopoulos, D. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01426-1 · Cited by 1,263
Witzig, T. E., Gordon, L. I., Cabanillas, F., Czuczman, M. S., Emmanouilides, C., Joyce, R., Pohlman, B. L., Bartlett, N. L., Wiseman, G. A., Padre, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.076 · Cited by 1,170
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Yuan, F., Leunig, M., Huang, S. K., Berk, D. A., Papahadjopoulos, D., & Jain, R. K. (1994) · PubMed · Cited by 908
Sievers, E. L., Larson, R. A., Stadtmauer, E. A., Estey, E., Löwenberg, B., Dombret, H., Karanes, C., Theobald, M., Bennett, J. M., Sherman, M. L., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.13.3244 · Cited by 899
Improving the efficacy of antibody-based cancer therapies
Carter, P. (2001) · Nature Reviews Cancer · doi:10.1038/35101072 · Cited by 833
Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G. T., Shalaby, R., Baselga, J. M., Shao, Y. Y., Nielsen, U. B., Marks, J. D., Moore, D. H., et al. (2002) · Clinical Cancer Research · Cited by 766
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 629
Olsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., Vonderheid, E., Jegasothy, B., Wood, G., Gordon, M., Heald, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.376 · Cited by 609
Kaminski, M. S., Zelenetz, A. D., Press, O. W., Saleh, M., Leonard, J., Fehrenbacher, L., Lister, T. A., Stagg, R. J., Tidmarsh, G. F., Kroll, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.19.3918 · Cited by 584
Needham, D., & Dewhirst, M. W. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00233-2 · Cited by 570
Kong, G., Anyarambhatla, G., Petros, W. P., Braun, R. D., Colvin, O. M., Needham, D., & Dewhirst, M. W. (2000) · PubMed · Cited by 505
Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum-Shavit, F., Qazen, M. M., & Zalipsky, S. (1999) · Bioconjugate Chemistry · doi:10.1021/bc9801124 · Cited by 468
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Kreitman, R. J., Wilson, W. H., White, J. D., Stetler-Stevenson, M., Jaffe, E. S., Giardina, S., Waldmann, T. A., & Pastan, I. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.8.1622 · Cited by 420
Vose, J. M., Link, B. K., Grossbard, M. L., Czuczman, M., Grillo-Lopez, A., Gilman, P., Lowe, A., Kunkel, L. A., & Fisher, R. I. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.389 · Cited by 417
Medical Applications of Liposomes
(1998) · Elsevier eBooks · doi:10.1016/b978-0-444-82917-7.x5000-5 · Cited by 416
Juweid, M. E., Neumann, R. D., Paik, C. H., Pérez-Bacete, M., Sato, J., van Osdol, W. W., & Weinstein, J. N. (1992) · PubMed · Cited by 406
Tumor targeting using anti-her2 immunoliposomes
Park, J. W., Kirpotin, D. B., Hong, K., Shalaby, R., Shao, Y., Nielsen, U. B., Marks, J. D., Papahadjopoulos, D., & Benz, C. C. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00315-7 · Cited by 335
Brekken, R. A., Overholser, J. P., Stastny, V., Waltenberger, J. L., Minna, J. D., & Thorpe, P. E. (2000) · PubMed · Cited by 331
Targeted therapy of cancer with radiolabeled antibodies.
Goldenberg, D. M. (2002) · PubMed · Cited by 318
Hansen, C. B., Kao, G. Y., Moase, E. H., Zalipsky, S., & Allen, T. M. (1995) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(95)00138-s · Cited by 309
Self-citation(2000) · PubMed · Cited by 295
Strategies for enzyme/prodrug cancer therapy.
Xu, G., & McLeod, H. L. (2001) · PubMed · Cited by 279
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
Dubowchik, G. M., & Walker, M. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00018-2 · Cited by 277
Randomized Phase II Study of BR96-Doxorubicin Conjugate in Patients With Metastatic Breast Cancer
Tolcher, A. W., Sugarman, S., Gelmon, K. A., Cohen, R., Saleh, M., Isaacs, C., Young, L., Healey, D., Onetto, N., & Slichenmyer, W. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.478 · Cited by 271
Torchilin, V. P., Levchenko, T. S., Lukyanov, A. N., Khaw, B. A., Klibanov, A. L., Rammohan, R., Samokhin, G. P., & Whiteman, K. R. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2728(01)00165-7 · Cited by 271
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Ishida, O., Maruyama, K., Tanahashi, H., Iwatsuru, M., Sasaki, K., Eriguchi, M., & Yanagie, H. (2001) · Pharmaceutical Research · doi:10.1023/a:1010960900254 · Cited by 257
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
de Menezes, D. E. L., Pilarski, L. M., & Allen, T. M. (1998) · PubMed · Cited by 257
Self-citationReardon, D. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1389 · Cited by 255
A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs
Ishida, T., Iden, D. L., & Allen, T. M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01320-4 · Cited by 246
Self-citationAn Address System in the Vasculature of Normal Tissues and Tumors
Ruoslahti, E., & Rajotte, D. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.813 · Cited by 239
Iden, D. L., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00357-1 · Cited by 220
Self-citationIshida, T., Kirchmeier, M. J., Moase, E. H., Zalipsky, S., & Allen, T. M. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00409-6 · Cited by 216
Self-citationMaynard, J., & Georgiou, G. (2000) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.2.1.339 · Cited by 206
Moreira, J. N., Ishida, T., Gaspar, R. S., & Allen, T. M. (2002) · Pharmaceutical Research · doi:10.1023/a:1014434732752 · Cited by 183
Self-citationWiseman, G. A., White, C. A., Sparks, R. B., Erwin, W. D., Podoloff, D. A., Lamonica, D., Bartlett, N. L., Anthony Parker, J., Dunn, W. L., Spies, S. M., et al. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00107-x · Cited by 183
Baselga, J. (2001) · Oncology · doi:10.1159/000055397 · Cited by 180
Selective activation of anticancer prodrugs by monoclonal antibody–enzyme conjugates
Senter, P. D., & Springer, C. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00206-x · Cited by 178
Nielsen, U. B., Kirpotin, D. B., Pickering, E. M., Hong, K., Park, J. W., Refaat Shalaby, M., Shao, Y., Benz, C. C., & Marks, J. D. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00256-2 · Cited by 177
Noonberg, S. B., & Benz, C. C. (2000) · Drugs · doi:10.2165/00003495-200059040-00003 · Cited by 173
Salvatore, G., Beers, R., Margulies, I., Kreitman, R. J., & Pastan, I. H. (2002) · PubMed · Cited by 153
On the mechanisms of internalization and intracellular delivery mediated by pH-sensitive liposomes
Simões, S., Slepushkin, V., Düzgüneş, N., & de Lima, M. C. P. (2001) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00389-3 · Cited by 148
Veenendaal, L. M., Jin, H., Ran, S., Cheung, L. H., Navone, N. M., Marks, J. W., Waltenberger, J. L., Thorpe, P. E., & Rosenblum, M. G. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122157899 · Cited by 142
PDEPT: polymer-directed enzyme prodrug therapy
Satchi, R., Connors, T. A., & Duncan, R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2026 · Cited by 132
Antibody-directed enzyme prodrug therapy: efficacy and mechanism of action in colorectal carcinoma.
Napier, M. P., Sharma, S., Springer, C. J., et al. (2000) · PubMed · Cited by 128
Boman, N. L., Masin, D., Mayer, L. D., Cullis, P. R., & Bally, M. B. (1994) · PubMed · Cited by 126
Therapeutic opportunities for targeted liposomal drug delivery
Allen, T. M., & Moase, E. H. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00402-4 · Cited by 126
Self-citationTurk, M. J., Reddy, J. A., Chmielewski, J. A., & Low, P. S. (2002) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(01)00441-2 · Cited by 123
Messmann, R. A., Vitetta, E. S., Headlee, D. J., Senderowicz, A. M., Figg, W. D., Schindler, J. D., Michiel, D. F., Creekmore, S. P., Steinberg, S. M., Köhler, D., et al. (2000) · PubMed · Cited by 120
Juweid, M. E., Stadtmauer, E. A., Hajjar, G., Sharkey, R. M., Suleiman, S., Luger, S. M., Swayne, L. C., Alavi, A. A., & Goldenberg, D. M. (1999) · PubMed · Cited by 120
Frankel, A. E., Powell, B. L., Hall, P. D., Case, L. D., & Kreitman, R. J. (2002) · PubMed · Cited by 113
Design of novel bioconjugates for targeted drug delivery
Lu, Z., Shiah, J.-G., Sakuma, S., Kopečková, P., & Kopec̆ek, J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00495-3 · Cited by 103
Epenetos, A. A., Hird, V., Lambert, H. E., Mason, P., & Coulter, C. (2000) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2000.99510.x · Cited by 103
Duvic, M. A., Kuzel, T. M., Olsen, E. A., Martin, A., Foss, F. M., Kim, Y. H., HEALD, P. W., Bacha, P., NICHOLS, J. C., & Liepa, A. M. (2002) · Clinical Lymphoma · doi:10.3816/clm.2002.n.003 · Cited by 99
Pretargeting with the Affinity Enhancement System for Radioimmunotherapy
Barbet, J., Kraeber‐Bodéré, F., Vuillez, J.-P., Gautherot, E., Rouvier, É., & Chatal, J. (1999) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1999.14.153 · Cited by 96
Goldenberg, D. M. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(01)00108-1 · Cited by 95
pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system
Hong, M.-S., Lim, S., Oh, Y., & Kim, C. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021771913 · Cited by 88
Transferrin-mediated targeting of hypericin embedded in sterically stabilized PEG-liposomes
Derycke, A., & de Witte, P. A. M. (2002) · International Journal of Oncology · doi:10.3892/ijo.20.1.181 · Cited by 83
Liposome targeting to tumors using vitamin and growth factor receptors
Drummond, D. C., Hong, K., Park, J. W., Benz, C. C., & Kirpgtin, D. B. (2000) · Vitamins and hormones · doi:10.1016/s0083-6729(00)60022-5 · Cited by 77
Gautherot, E., Rouvier, É., Daniel, L., Loucif, E., Bouhou, J., Manetti, C., Martin, M., Doussal, J. M. L., & Barbet, J. (2000) · PubMed · Cited by 75
Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin
Schnell, R., Vitetta, E. S., Schindler, J. D., Borchmann, P., Barth, S., Ghetie, V. F., Hell, K., Drillich, S., Diehl, V., & Engert, A. (2000) · Leukemia · doi:10.1038/sj.leu.2401626 · Cited by 75
Baluna, R. G., Coleman, E. J., Jones, C. D., Ghetie, V. F., & Vitetta, E. S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4954 · Cited by 74
Leonard, J. P., & Link, B. K. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.30149 · Cited by 74
Vascular endothelial growth factor and vascular targeting of solid tumors.
Brekken, R. A., & Thorpe, P. E. (2001) · PubMed · Cited by 73
Differences in the intracellular fate of free and polymer-bound doxorubicin
Hovorka, O., Šťastný, M., Etrych, T., Šubr, V., Strohalm, J., Ulbrich, K., & Říhová, B. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00016-0 · Cited by 72
David, A., Kopečková, P., Rubinstein, A., & Kopec̆ek, J. (2001) · Bioconjugate Chemistry · doi:10.1021/bc010026v · Cited by 71
Peipp, M., Küpers, H., Saul, D., Schlierf, B., Greil, J., Zunino, S. J., Gramatzki, M., & Fey, G. H. (2002) · PubMed · Cited by 70
de Menezes, D. E. L., Kirchmeier, M. J., Gagné, J.-F., Pilarski, L. M., & Allen, T. M. (1999) · Journal of Liposome Research · doi:10.3109/08982109909024786 · Cited by 69
Self-citationEngineered antibodies take center stage
Huston, J. S., & George, A. J. T. (2001) · Human Antibodies · doi:10.3233/hab-2001-103-405 · Cited by 68
Monoclonal Antibodies in the Treatment of Malignancy: Basic Concepts and Recent Developments
Dillman, R. O. (2001) · Cancer Investigation · doi:10.1081/cnv-100107745 · Cited by 67
Multani, P. S., O'Day, S. J., Nadler, L. M., & Grossbard, M. L. (1998) · PubMed · Cited by 61
Allen, T. M., Sapra, P., Moase, E. H., Moreira, J. N., & Iden, D. (2002) · Journal of Liposome Research · doi:10.1081/lpr-120004771 · Cited by 58
Self-citationde Menezes, D. E. L., Pilarski, L. M., Belch, A. R., & Allen, T. M. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00203-0 · Cited by 56
Self-citationGrossbard, M. L., Multani, P. S., Freedman, A. S., O'Day, S. J., Gribben, J. G., Rhuda, C., Neuberg, D. S., & Nadler, L. M. (1999) · PubMed · Cited by 49
Antitumor Efficacy of Taxane Liposomes on a Human Ovarian Tumor Xenograft in Nude Mice†
Sharma, A., Straubinger, R. M., Ojima, I., & Bernacki, R. J. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600841204 · Cited by 46
Lindén, O., Tennvall, J., Cavallin-Ståhl, E. K., Darte, L., Garkavij, M., Lindner, K., Ljungberg, M. H., Ohlsson, T. G., Sjögreen, K., Wingårdh, K., et al. (1999) · PubMed · Cited by 46
Monoclonal Antibody Therapy for Lymphoma
Dillman, R. O. (2001) · Cancer Practice · doi:10.1046/j.1523-5394.2001.009002071.x · Cited by 45
Casey, J. L., Napier, M. P., King, D. J., Pedley, R. B., Chaplin, L. C., Weir, N., Skelton, L., Green, A. J., Hope‐Stone, L., Yarranton, G. T., et al. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600198 · Cited by 43
Radioimmunotherapy of B-cell non-Hodgkin's lymphoma
Postema, E. J., Boerman, O. C., Oyen, W. J. G., Raemaekers, J. M. M., & Corstens, F. H. M. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100570 · Cited by 42
Vascular-Targeted Radioimmunotherapy with the Alpha-Particle Emitter 211 At
Kennel, S. J., Mirzadeh, S., Eckelman, W. C., Waldmann, T. A., Garmestani, K., Yordanov, A. T., Stabin, M. G., & Brechbiel, M. W. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)157[0633:vtrwta]2.0.co;2 · Cited by 42
DeNardo, G. L., DeNardo, S. J., OʼDonnell, R. T., et al. (2000) · Clinical Lymphoma · doi:10.3816/clm.2000.n.010 · Cited by 41
Pavlínková, G., Colcher, D. M., Booth, B. J. M., Goel, A., Wittel, U. A., & Batra, S. K. (2001) · International Journal of Cancer · doi:10.1002/ijc.1523 · Cited by 41
Antibody therapy for residual disease in acute myelogenous leukemia
Jurcic, J. (2001) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00132-3 · Cited by 39
Increased liposome extravasation in selected tissues: effect of substance P.
Rosenecker, J., Zhang, W., Hong, K., Lausier, J., Geppetti, P., Yoshihara, S., Papahadjopoulos, D., & Nadel, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7236 · Cited by 37
Li, W. M., Mayer, L. D., & Bally, M. B. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.976 · Cited by 37
Designing Immunotoxins for Cancer Therapy
Pennell, C. A., & Erickson, H. A. (2002) · Immunologic Research · doi:10.1385/ir:25:2:177 · Cited by 33
Folate-Targeted Liposomes for Drug Delivery
Lee, R. J., & Low, P. S. (1997) · Journal of Liposome Research · doi:10.3109/08982109709035512 · Cited by 32
Targeted sterically stabilized liposomal drug delivery
Allen, T. M., HANSEN, C. B., & Stuart, D. D. (1998) · Elsevier eBooks · doi:10.1016/b978-044482917-7/50018-1 · Cited by 31
Self-citationPhase I Trial of Anti-B4-Blocked Ricin in Pediatric Patients With Leukemia and Lymphoma
Dinndorf, P. A., Krailo, M., Liu‐Mares, W., Frierdich, S. A., Sondel, P. M., & Reaman, G. H. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00008 · Cited by 30
Stadtmauer, E. A. (2002) · Clinical Lymphoma · doi:10.3816/clm.2002.s.005 · Cited by 18
Cited by
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Liposomal drug delivery systems: From concept to clinical applications
Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839
Self-citationCancer nanotechnology: opportunities and challenges
Ferrari, M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1566 · Cited by 4,558
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Self-citationNanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Metadata
- Authors
- Allen, T. M.
- Venue
- Nature Reviews Cancer
- Published
- 2002-10
- Volume
- 2
- Issue
- 10
- Pages
- 750-763
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2041759339
- Cited by
- 1,647
- References
- 97
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.